Centre for Addiction and Mental Health
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- -
- Established
- 1998-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
334
Active:12
Completed:205
Trial Phases
6 Phases
Early Phase 1:4
Phase 1:14
Phase 2:29
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (313 trials with phase data)• Click on a phase to view related trials
Not Applicable
239 (76.4%)Phase 2
29 (9.3%)Phase 4
26 (8.3%)Phase 1
14 (4.5%)Early Phase 1
4 (1.3%)Phase 3
1 (0.3%)Development and Evaluation of a Theory and Evidence-based Intervention to Reduce Hazardous Alcohol Consumption Among Treatment Seeking Smokers
Not Applicable
Not yet recruiting
- Conditions
- Alcohol Misuse
- First Posted Date
- 2025-11-14
- Last Posted Date
- 2025-11-14
- Lead Sponsor
- Centre for Addiction and Mental Health
- Target Recruit Count
- 77
- Registration Number
- NCT07228923
Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression
Not Applicable
Not yet recruiting
- Conditions
- Treatment-Resistant Depression
- Interventions
- First Posted Date
- 2025-10-08
- Last Posted Date
- 2025-10-08
- Lead Sponsor
- Centre for Addiction and Mental Health
- Target Recruit Count
- 40
- Registration Number
- NCT07211438
- Locations
- 🇨🇦
Toronto Western Hospital (University Health Network), Toronto, Ontario, Canada
🇨🇦Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Efficacy of an EMDR App for PTSD and SUD
Not Applicable
Not yet recruiting
- Conditions
- Posttraumatic Stress Disorder (PTSD)Substance Use Disorders
- First Posted Date
- 2025-08-28
- Last Posted Date
- 2025-08-28
- Lead Sponsor
- Centre for Addiction and Mental Health
- Target Recruit Count
- 24
- Registration Number
- NCT07146633
Do Antipsychotics Block Insulin Action in the Brain: is it a Class Effect?
Not Applicable
Not yet recruiting
- Conditions
- Brain Insulin SensitivityHealthy ControlsCognition
- Interventions
- First Posted Date
- 2025-08-07
- Last Posted Date
- 2025-08-07
- Lead Sponsor
- Centre for Addiction and Mental Health
- Target Recruit Count
- 35
- Registration Number
- NCT07109245
- Locations
- 🇨🇦
Centre for Addiction and Mental Health, Toronto, Ontario, Canada
THC Titration of High-Potency Cannabis Concentrates
Not Applicable
Not yet recruiting
- Conditions
- THC
- Interventions
- Drug: Cannabis (30% THC Concentrate)Drug: Cannabis (60% THC Concentrate)Drug: Cannabis (90% THC Concentrate)
- First Posted Date
- 2025-08-06
- Last Posted Date
- 2025-08-06
- Lead Sponsor
- Centre for Addiction and Mental Health
- Target Recruit Count
- 48
- Registration Number
- NCT07105449
- Locations
- 🇨🇦
Centre for Addiction and Mental Health, Toronto, Ontario, Canada
- Prev
- 1
- 2
- 3
- 4
- 5
- 67
- Next
News
Viatris Launches First Clozapine Orally Disintegrating Tablet in Canada for Treatment-Resistant Schizophrenia
Viatris has launched Gen-Clozapine orally disintegrating tablets in Canada, marking the first availability of this formulation for treatment-resistant schizophrenia patients.